Nomura Holdings, Inc.

NYSE:NMR

Financial - Capital Markets

Financial Services
$9.23 -1.32%

-$0.12 today

Market cap
$27.29B
Beta
0.61
P/E (TTM)
0.3
EPS (TTM)
$4,986.67
Dividend yield
3.55%
52W Low $6.02High $9.58

Volume 3.51M

Average 1.75M

NMR Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

Nomura Holdings, Inc.NYSE: NMR

Operating Expenses · Q1 FY2027 · quarter ended Jun 2026

Operating expenses grows, but more slowly than its trailing trend

Q1 FY2027 operating expenses of ¥400.84B rose 25.9% year over year, behind the +42.7% change in trailing-twelve-month operating expenses. Sequentially, it fell 34.9% from the prior quarter. Over 3 fiscal years it compounded at +17.8% a year.

Context

  • Operating expenses amounted to 34.2% of revenue in FY2026, up 7.8 pp from a year earlier.
  • Operating expenses increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +25.9% toward the trailing-twelve-month pace of +42.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
¥400.84B-34.9% QoQ
Last fiscal yearMar 2026
¥1.63T+36.8% YoY
LTMJun 2026
¥1.71T+42.7% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+25.9%——
1 year+36.8%——
3-year CAGR+17.8%——
5-year CAGR——
10-year CAGR——

Operating Expenses history

JPY · from the income statement

Latest · FY2026
1.63T JPY
Year-over-year change
+36.8%
4-year CAGR
+15.4%

Operating Expenses vs competitors

How NMR compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +42.7% is the 4th highest of 9, against a peer median of +29.5%.
  • Operating expenses amounts to 39.5% of revenue for NMR, versus a peer median of 52.5%.
NMR Competitors
Operating Expenses for NMR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NMRNomura Holdings, Inc.LTM Jun 2026¥1.71T JPY+42.7%+17.8%39.5%
MSMorgan StanleyLTM Sep 2026$52.02B USD+21.8%+6.8%40.1%
GSThe Goldman Sachs Group, Inc.LTM Sep 2026$40.17B USD+11.3%+6.4%32.5%
UBSUBS Group AGLTM Jun 2026$39.19B USD+9.3%+20.2%51.6%
JEFJefferies Financial Group Inc.LTM Aug 2026$7.5B USD+179.9%+70.8%60.2%
SFStifel Financial Corp.LTM Sep 2026$4.04B USD-8.1%+10.3%60.4%
EVREvercore Inc.LTM Jun 2026$3.62B USD+37.3%+14.2%76.4%
LAZLazard LtdLTM Sep 2026$1.8B USD+149.6%-2.9%53.5%
OPYOppenheimer Holdings Inc.LTM Mar 2026$852.28M USD+416.6%+47.9%49.7%
Peer median (excluding NMR) —+29.5%+12.2%52.5%

Competitors are the stored peer set for NMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

JPY
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue1.37T2.3T3.97T4.51T4.76T
Cost of Revenue230.11B1.15T2.6T2.84T2.59T
Gross Profit1.14T1.14T1.38T1.66T2.17T
Gross Margin83.3%49.9%34.7%36.9%45.6%
Research & Development00000
Selling, General & Admin529.51B605.79B673.52B732.39B1.37T
Operating Expenses917.09B995.5B1.1T1.19T1.63T
Depreciation & Amortization59.52B61.42B61.34B61.65B68.27B
EBITDA286.15B210.9B335.19B533.62B608.09B
EBITDA Margin20.8%9.2%8.4%11.8%12.8%
Operating Income226.62B149.47B273.85B471.96B539.82B
Operating Margin16.5%6.5%6.9%10.5%11.3%
Interest Income284.22B1.11T2.62T2.93T2.67T
Interest Expense230.11B1.15T2.6T2.84T2.59T
Other Income / Expenses00000
Income Before Tax226.62B149.47B273.85B471.96B539.82B
Pre-Tax Margin16.5%6.5%6.9%10.5%11.3%
Income Tax Expense80.09B57.8B96.63B124.71B165.44B
Net Income143B92.79B165.86B340.74B362.13B
Net Margin10.4%4.0%4.2%7.6%7.6%
EPS (Basic)46.6830.8654.97115.30123.08
EPS (Diluted)45.2329.7452.75111.03118.99
Weighted Avg Shares3.06B3.01B3.02B2.96B2.94B
Weighted Avg Shares (Diluted)3.16B3.11B3.14B3.07B3.04B

Nomura Holdings, Inc.

NYSE:NMR

Intrinsic Alpha fair value

Locked

Current Price

$9.23

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.